Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.
Press releases published on May 28, 2025

Sana Biotechnology to Present at June 2025 Investor Conferences
SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in June. …

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
DALLAS, May 28, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …

argenx Announces Results of Annual General Meeting of Shareholders
May 28, 2025 – 10:01 PM CET Amsterdam, the Netherlands – argenx SE (Euronext …

Nutanix Reports Third Quarter Fiscal 2025 Financial Results
Delivers Outperformance Across All Guided Metrics Reports 18% YoY ARR Growth and Strong Free Cash Flow SAN JOSE, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced financial …

Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …

Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and …

Taysha Gene Therapies Announces Pivotal Part B Trial Design Details for TSHA-102 in Rett Syndrome Enabled by IRSF Natural History Data and Positive Clinical Data from Part A of the REVEAL Adult/Adolescent and Pediatric Trials Evaluating TSHA-102
Natural history data analysis established patients ≥ six years of age are in developmental plateau, with a ~0% likelihood of gaining/regaining developmental milestones across the core functional domains of Rett syndrome Written alignment from FDA supports …

Disc Medicine to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …

EyePoint Announces Participation at Upcoming Investor Conferences
WATERTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced …

ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference
BERKELEY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief executive officer, …

DeFi Development Corp. to Host X Spaces Event: “Validators 101: Powering Solana’s Future”
BOCA RATON, FL, May 28, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) today announced that it will host a live X Spaces conversation on Friday, May 30, 2025, at 1:00 p.m. Eastern Time, titled “Validators 101: Powering …

c/side Evaluated by VikingCloud Against New PCI DSS 4.0.1 Security Requirements
SAN FRANCISCO, May 28, 2025 (GLOBE NEWSWIRE) -- c/side, which specializes in securing vulnerable web dependencies, today announced the results of a technical review conducted by global cybersecurity firm, VikingCloud. The assessment evaluated how c/side’s …

מועד אחרון לתביעה נגד CERE: רוזן, עורכי דין למשפט לאומי, מעודדים את משקיעי Cerevel Therapeutics Holdings, Inc. שצברו הפסדים של יותר מ- 100 אלף דולר, להבטיח ייעוץ לפני המועד האחרון החשוב של 3 ביוני בתביעה ייצוגית בניירות ערך – CER…
ניו יורק, May 28, 2025 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לאנשים או לגופים כי (1) מכרו או סילקו בדרך אחרת את המניות הרגילות הנסחרות בבורסה של Cerevel Therapeutics Holdings, …

CERE DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CERE
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that (1) sold or otherwise disposed of the publicly-traded common stock of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) …

Shareholders who lost money on Red Cat Holdings, Inc. (NASDAQ: RCAT) Should Contact Wolf Haldenstein
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman …

Comprehensive Guide to Leading Bitcoin Mining Platforms: Top 7 Best Cryptocurrency Cloud Mining Platforms to Make Money in 2025
Wilmington, Delaware, May 28, 2025 (GLOBE NEWSWIRE) -- In 2025, Bitcoin, Litecoin, and Dogecoin continue to dominate the crypto mining scene. These three coins remain top choices for investors due to their strong market capitalization, consistent demand, …

WinnerMining: Keeping up with the times — From tradition to intelligence, potential passive income daily
Norwich, United Kingdom, May 28, 2025 (GLOBE NEWSWIRE) -- Since 2013, the cloud mining market has been constantly evolving, mining equipment has been constantly updated, and group sizes have also been separated or expanded in the cloud mining pie. As the …